The two-day event includes over 60 speakers and anticipates over 400 attendees, with more than 80 start-ups also represented.
The programme covers key topics such as scaling synthetic biology innovations from lab to market, regulatory developments, IP law, sustainable bio-economy, investment trends, and infrastructure for scale-up. Panel sessions, company presentations, and plenary talks feature across both days
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
| Headless Content Management with Blaze